EP 2205194 B1 20150513 - ALLOPLASTIC INJECTABLE DERMAL FILLER AND METHODS OF USE THEREOF
Title (en)
ALLOPLASTIC INJECTABLE DERMAL FILLER AND METHODS OF USE THEREOF
Title (de)
ALLOPLASTISCHER INJIZIERBARER HAUTFÜLLER UND ANWENDUNGSVERFAHREN DAFÜR
Title (fr)
CHARGE DERMIQUE INJECTABLE ALLOPLASTIQUE ET PROCÉDÉS D'UTILISATION DE CELLE-CI
Publication
Application
Priority
- US 2008081608 W 20081029
- US 92693007 A 20071029
Abstract (en)
[origin: US2009110736A1] A composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent is provided. A method of making a composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent, said method comprising admixing a biocompatible and pliable material with a physiologically acceptable suspending agent, is also provided. A method of augmenting soft tissue to provide long-term reduction of a skin defect, said method comprising stimulating collagen beneath the skin defect is further provided. In an embodiment of the method of augmenting soft tissue, the stimulation of collagen production is effected by injecting into the deep reticular dermis an a dermal filler, said dermal filler being an alloplastic injectable suspension and comprising a biocompatible and pliable material and a physiologically acceptable suspending agent.
IPC 8 full level
A61F 2/00 (2006.01); A61F 13/00 (2006.01); A61K 9/70 (2006.01); A61K 31/78 (2006.01)
CPC (source: EP US)
A61K 8/02 (2013.01 - EP US); A61K 8/65 (2013.01 - EP US); A61K 8/735 (2013.01 - EP US); A61K 8/8147 (2013.01 - EP US); A61K 8/8152 (2013.01 - US); A61K 9/1635 (2013.01 - EP US); A61K 9/1652 (2013.01 - EP US); A61K 9/1658 (2013.01 - EP US); A61K 31/78 (2013.01 - EP US); A61L 27/16 (2013.01 - EP US); A61L 27/26 (2013.01 - EP US); A61P 17/00 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61Q 19/00 (2013.01 - US); A61Q 19/08 (2013.01 - EP US); A61K 2800/91 (2013.01 - EP US); A61L 2400/06 (2013.01 - EP US); A61L 2430/34 (2013.01 - EP US)
Citation (examination)
- ABELA-FORMANEK CLAUDETTE ET AL: "Biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in eyes with uveitis having cataract surgery: Long-term follow-up.", JOURNAL OF CATARACT AND REFRACTIVE SURGERY JAN 2011, vol. 37, no. 1, January 2011 (2011-01-01), pages 104 - 112, ISSN: 1873-4502
- TOGNETTO DANIELE ET AL: "Lens epithelial cell reaction after implantation of different intraocular lens materials: Two-year results of a randomized prospective trial.", OPHTHALMOLOGY, vol. 110, no. 10, October 2003 (2003-10-01), pages 1935 - 1941, ISSN: 0161-6420
- YAMANAKA YASUHIRO ET AL: "Polyubiquitination Events Mediate Polymethylmethacrylate (PMMA) Particle Activation of NF-kappa B Pathway", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 286, no. 27, July 2011 (2011-07-01), pages 23735 - 23741
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2009110736 A1 20090430; US 7910134 B2 20110322; CA 2703566 A1 20090507; CA 2703566 C 20160628; EP 2205194 A1 20100714; EP 2205194 A4 20101215; EP 2205194 B1 20150513; JP 2011502026 A 20110120; JP 5563984 B2 20140730; US 2011165210 A1 20110707; US 2015118274 A1 20150430; US 8956632 B2 20150217; WO 2009058883 A1 20090507
DOCDB simple family (application)
US 92693007 A 20071029; CA 2703566 A 20081029; EP 08845548 A 20081029; JP 2010532211 A 20081029; US 2008081608 W 20081029; US 201113047993 A 20110315; US 201514593385 A 20150109